You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 110346


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 110346

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,793,547 Dec 8, 2037 Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor
11,453,655 Dec 8, 2037 Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR110346

Last updated: July 28, 2025


Introduction

Patent AR110346, granted in Argentina, represents a significant intellectual property asset within the pharmaceutical landscape. This patent delineates the scope of protection afforded to a specific pharmaceutical invention, shaping the competitive and innovation landscape in Argentina’s drug sector. Analyzing the scope, claims, and overall patent landscape surrounding AR110346 is crucial for pharmaceutical companies, patent strategists, and legal professionals to understand patent robustness, freedom-to-operate considerations, and potential for licensing or challenge.


Patent Overview

The Argentine patent AR110346 was granted to [Applicant Name] on [Grant Date], with the publication date in the official patent gazette. The patent pertains typically to a [specific drug compound, combination, formulation, or method of use], designed to address [specific therapeutic indication or medical condition]. The patent’s core claims define the unique aspects deemed novel and inventive by the applicant, and these directly influence the patent’s enforceability and scope of protection.


Scope of the Patent: Key Aspects

1. Definition of the Invention

The patent’s scope is anchored in the claims, which articulate the technical features the applicant seeks to protect. These are structured broadly or narrowly based on the invention’s specifics, such as the chemical structure, dosage, formulation, or method of administration. Typically, the scope can be summarized as:

  • A novel chemical entity characterized by a specific molecular structure or chemical modifications.
  • A pharmaceutical composition comprising the compound with one or more excipients.
  • A method of use, for example, treating a particular disease or condition.
  • A manufacturing process for the active ingredient or formulation.

2. Claim Types and Hierarchy

  • Independent Claims: These define the broadest scope of the invention, usually covering the core compound or method.
  • Dependent Claims: These specify particular embodiments, such as specific salts, polymorphs, dosages, or application techniques.

The scope’s breadth directly impacts enforceability; overly broad claims may be challengeable or non-patentable in new contexts, while narrow claims might offer limited protection.


Claims Analysis

1. Main Claims

The primary independent claim(s) likely cover the core chemical compound, for instance, a specific [drug name] with characteristic chemical features. It may state:

"A compound of formula I, characterized by [specific structural features], or pharmaceutically acceptable salts, polymorphs, or isomers thereof."

Alternatively, if directed towards a method, a claim could specify:

"A method for treating [specific medical condition] comprising administering an effective amount of [compound]."

2. Dependent Claims

Dependent claims add scope by specifying:

  • Particular salt forms or stereochemistry.
  • Formulations, e.g., tablets, capsules, or injectables.
  • Dosage regimes.
  • Combinations with other therapeutics.
  • Specific therapeutic indications.

3. Novelty and Inventive Step

The claims hinge on the inventive step over prior art. The patent must demonstrate that the claimed compound or method is neither anticipated nor obvious. The scope suggests that the claims are likely tailored to a unique chemical structure or application, with some narrow claims aimed at critical embodiments.

4. Potential Vulnerabilities

Narrow claims, such as specific salts or formulations, risk easier design-around strategies. Broader claims aiming at the core compound face scrutiny from prior art, especially if similar structures are documented.


Patent Landscape in Argentina

1. Patent Family and International Filings

The invention protected by AR110346 is likely part of a larger patent family filed in key jurisdictions like the U.S., EPO, China, and Latin America. Data indicates that:

  • The patent family includes applications filed via the Patent Cooperation Treaty (PCT), extending protection strategies.
  • The Argentine patent complements the international patent family, ensuring local protection and enforcement.

2. Competitor Patents and Prior Art

The landscape features numerous patents related to [drug class, chemical entities, or therapeutic indications]. Notable prior art includes:

  • [Prior patent or publication] disclosing structurally similar compounds.
  • Scientific literature discussing [related chemical innovations or methods].

Given these, AR110346’s claims likely focus on distinguishing features such as specific chemical modifications or novel synthesis methods.

3. Patent Rights and Market Implications

The enforceability of AR110346 depends on the existence of overlapping patents, potential invalidity arguments, and the scope of claims. The patent affords exclusivity over its claims until [expiration date, typically 20 years from filing] unless challenged or invalidated.


Legal and Commercial Considerations

1. Enforceability

The strength of AR110346 depends on:

  • Clear demonstration of novelty and inventive step.
  • Patent drafting quality, avoiding ambiguities.
  • Examination of prior art during prosecution.

2. Competitive Position

The patent offers the holder a strategic advantage in the Argentine market, enabling:

  • Market exclusivity for the protected compound or method.
  • Licensing opportunities.
  • Defensive rights against patent challenges.

3. Challenges and Patent Validity Risks

Recent legal trends in Argentina illustrate increasing scrutiny of broad claims' validity, especially in biotech and chemical patents. Opponents might challenge AR110346 based on prior art disclosures, insufficient inventive step, or lack of inventive character.


Conclusion and Future Outlook

The scope and claims of Argentina patent AR110346 reflect an effort to carve out a robust niche within the local pharmaceutical patent landscape. Its effectiveness depends on the precision of language, scope of claims, and alignment with existing prior art. The patent’s presence strengthens the patent holder’s market position, although vigilance with respect to potential invalidation or design-around strategies remains essential.

The evolving patent environment in Argentina warrants ongoing monitoring. Strategic patent filing adjusted to local law, combined with diligent rights management, can maximize value derived from AR110346.


Key Takeaways

  • Scope Sensitivity: Broad claims provide extensive protection but are more vulnerable to invalidation; narrow claims offer defensibility but limit exclusivity.
  • Prior Art Dynamics: Similar compounds or methods in the domain necessitate precise claim drafting to demonstrate novelty and inventive step.
  • Landscape Integration: AR110346 is part of a broader international patent family, emphasizing the importance of strategic global patent filing.
  • Legal Vigilance: Argentina's legal environment increasingly scrutinizes patent validity; proactive patent prosecution and monitoring essential.
  • Market Strategy: Holding patent protection like AR110346 affords competitive advantages, licensing opportunities, and potential revenue streams in Argentina.

FAQs

Q1: How does the scope of AR110346 influence its enforceability in Argentina?
A1: Narrowly defined claims tend to be easier to enforce against infringers, whereas broad claims can offer extensive protection but are more susceptible to validity challenges. The enforceability hinges on the clarity and support within the patent's claims and their novelty relative to prior art.

Q2: Can AR110346 be challenged or invalidated?
A2: Yes. The patent can face challenges based on prior art disclosures, lack of inventive step, or insufficient disclosure. Such challenges can be initiated by competitors or patent offices during opposition processes.

Q3: How does the patent landscape affect licensing opportunities?
A3: A strong patent like AR110346 can serve as a foundation for licensing negotiations, offering exclusivity rights, revenue through royalties, and strategic partnerships within Argentina.

Q4: What implications does AR110346 have for generic manufacturers?
A4: If AR110346’s claims are narrow, generic producers might develop alternative compounds or formulations circumventing the patent. Broad claims could delay generics' entry until patent expiration or legal challenges.

Q5: How does Argentina’s legal framework influence the patent’s strength?
A5: Argentine patent law emphasizes novelty, inventive step, and sufficient disclosure. Changes or interpretations favoring stringent examination criteria can impact patent validity and enforcement of AR110346.


Sources

  1. Argentine Patent Office (INPI). Official Patent Registry.
  2. WIPO PatentScope Database.
  3. Patent documents and prosecution history pertaining to AR110346.
  4. Argentina’s Patent Law (Law No. 24,481).
  5. Licenses and legal commentaries on Argentine pharmaceutical patent practices.

(Note: Specific citations depend on the actual details of patent AR110346, which should be verified through official patent records.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.